BLINATUMOMAB

This medication is used to treat a certain type of cancer (acute lymphocytic leukemia-ALL). Acute lymphocytic leukemia is a cancer of the blood in which a particular kind of white blood cell is growing out of control. Blinatumomab belongs to a class of drugs known as monoclonal antibodies. It works by slowing or stopping the growth of cancer cells. Before you receive this medication, you may be given a corticosteroid medicine to help reduce infusion reactions. This medication comes in an injectable form to be given directly into the vein by continuous IV infusion for 4 weeks (28 days), followed by a 2 week break.